Baker County Medical Services Posts Its Charges on Their Website
MACCLENNY, Fla. -- Baker County Medical Services which operates Ed Fraser Memorial Hospital in Macclenny, Florida announced today that they have posted all of their hospital charges contained in their Charge Master on their website.
Ophthalmic Research and Development Company Launches Adjunctive Eyelid Therapy and Hygiene Product
RICHMOND, Texas -- CYNACON/OCuSOFT(R) (OCuSOFT, Inc.) specializes in ophthalmic research, development and supply to ophthalmologists and optometrists. They are excited to announce a new and innovative prescription-only ALODOX(R) Convenience Kit for adjunctive eyelid therapy and hygiene.
OCuSOFT, Inc. Names Lawrence A. Yannuzzi, M.D. to Medical Scientific Advisory Board
RICHMOND, Texas -- CYNACON / OCuSOFT (OCuSOFT, Inc.), a company specializing in ophthalmic research, development and supply to ophthalmologists and optometrists, today announced the appointment of Lawrence A. Yannuzzi, M.D. to its Medical Scientific Advisory Board.
iPhone Browses Diagnostic Heart Images with HeartIT Medical Imaging Solution
DURHAM, N.C. -- Heart Imaging Technologies (HeartIT) announced today that medical images can be viewed on Apple's new iPhone. Physicians can simply click on a web link sent via email by one of their colleagues, enter their password, and, for example, instantly view movies of a patient's beating heart halfway around the world.
Fertility and Hormonal Health Expert Dr. Robert Greene to Lead Sacramento Reproductive Practice
SACRAMENTO, Calif. -- The Sher Institute for Reproductive Medicine(SM) - Sacramento (SIRM-Sacramento) has announced that Dr. Robert Greene will join as full-time medical director, operating out of the Sacramento headquarters as well as the Pleasanton and newly-established Redding satellite offices.
Biotechnology Company Takes Aim at Pancreatic Cancer With an Advanced Phase I/II Clinical Trial Using Rexin-G™
SAN MARINO, Calif. -- Epeius Biotechnologies Corporation announced today that an advanced Phase I/II clinical trial using intravenous Rexin-G(TM) for pancreatic cancer that is refractory to standard chemotherapy will open in the summer of 2007 in Los Angeles, California. Rexin-G is the world's first tumor-targeted injectable gene delivery system that is designed to seek out and destroy both primary tumors and metastatic cancers that have spread throughout the body.
Previser Corp. and National Children's Oral Health Foundation Launch Initiative to Reduce Oral Disease Among Disadvantaged Populations
CHARLOTTE, N.C. -- The National Children's Oral Health Foundation (NCOHF) and PreViser Corporation today announced a joint initiative to collaborate in an effort to improve the oral health of low income children nationwide. The NCOHF, whose non-profit mission is to eliminate oral disease, and promote overall health and well-being for economically disadvantaged children.
Sher Institute Infertility Practice In Monmouth County, NJ Announces New Medical Director and Expanded Operations
SHREWSBURY, N.J. -- The Sher Institute for Reproductive Medicine(SM)-New Jersey (SIRM(TM)-NJ), part of one of the largest and fastest growing infertility networks in the United States, has announced that Douglas Rabin, MD, has joined SIRM's Monmouth/Ocean County office (located in Shrewsbury) as its Medical Director.
New Sher Institute IVF Office in Bergen County to Offer Exclusive Access to Breakthrough Technology
FAIR LAWN, N.J. -- The Sher Institute for Reproductive Medicine - New Jersey (SIRM-NJ), part of one of the largest and fastest growing infertility networks in the United States, announces the opening of a new office in Bergen County. Located in Fair Lawn, New Jersey, the office will have exclusive access in the area to various SIRM breakthrough technologies in the field of In Vitro Fertilization.
Crescent Diagnostics Announces Positive Clinical Results for its Novel Bone Quality Test, BQT™
LONDON, UK -- Crescent Diagnostics Ltd ("Crescent"), today announced the publication of a recent study demonstrating the potential of the Bone Quality Test, BQT(TM) to diagnose osteoporosis. More women at risk can be screened with an accurate, simple to use test which does not require a hospital visit.